[MR vaccine]

Area of Science:

• Public Health
• Epidemiology
• Vaccinology

Context:

• Measles immunization was implemented in 1978 and rubella in 1977.
• Outbreaks of measles in 2001 and congenital rubella syndrome in 2004 necessitated combined measles-rubella (MR) vaccination recommendations.
• Measles outbreaks in adolescents and adults occurred in 2007/08, leading to targeted catch-up campaigns.

Purpose:

• To evaluate the impact of vaccination strategies on measles and rubella incidence.
• To identify the need for further interventions to achieve measles elimination.
• To assess the effectiveness of catch-up vaccination campaigns.

Summary:

• Routine measles and rubella immunizations were introduced in the late 1970s.
• Despite initial success, outbreaks occurred in 2001 and 2004, prompting the recommendation of a combined measles-rubella (MR) vaccine for children.
• Targeted MR vaccination campaigns (MR III and IV) for adolescents were initiated in 2008 following outbreaks in this age group.
• Measles cases significantly reduced to 457 in 2010, nearing elimination goals.
• Promoting vaccine coverage for MR III and IV is essential for achieving measles elimination by 2012.

Impact:

• The study highlights the importance of sustained and targeted vaccination efforts in controlling vaccine-preventable diseases.
• Achieving high vaccine coverage in all age groups, including adolescents, is critical for disease elimination.
• The findings underscore the need for ongoing surveillance and responsive public health strategies.